Izotropic Corporation announced that it has engaged Dr. Craig Abbey, Ph.D., to develop and present proposed reader study designs to the FDA during the Company's pre-submission meeting for approval of its Breast CT Imaging System. Dr. Abbey will be working closely with Dr. Nosratieh to complete and present the application to the FDA, which includes product and indication for use statements, device labelling terms and future marketing claims which will be substantiated by the clinical and validation studies. Dr. Abbey has also joined the Company's growing Advisory Board and reflected on the Izotropic team and the reality of Breast CT FDA approval.